In a nutshell Scientists discovered that an enzyme called SSAT1 turns helpful immune cells into harmful ones in psoriasis, ...

Helix, a leader in population genomics and precision health, is announcing a new comprehensive clinico-genomic virtual registry of autoimmune disease patients. Consisting of over 23,000 individuals ...

While previous treatment approaches have mainly focused on inhibiting pro-inflammatory immune cells ... Drug to Fight Psoriasis Feb. 3, 2025 — Psoriasis is a chronic skin disease that manifests ...

Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as ...

Positive results were reported for Johnson & Johnson's psoriasis drug during.a late-breaking research session today at the ...

In the third episode of a six-part interview series on immunotherapy, Marc Voigt, CEO and Executive Director of Immutep ...

March is Women’s History month, dedicated to celebrating the contributions of women to society. March 8 is International ...

Psoriasis is a chronic, recurrent, inflammatory, and immune-mediated systemic disease influenced by genetic and environmental factors, significantly impacting patients' quality of life. The 2025 AAD ...

(NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating promising health innovations, today provided an update on its subsidiary, Adimune, Inc., (“Adimune”) ...

The global dermatology lasers market is set for substantial growth, increasing from USD 1,767.8 billion in 2023 to USD ...